Article
An albumin‑binding domain and targeting peptide‑based recombinant protein and its enediyne‑integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K‑ras mutation.
Oncology reports - 1 Mar 2020
Sheng Weijin, Geng Jing, Li Liang, Shang Yue, Jiang Min, Zhen Yongsu
Abstract excerpt
Efficient enrichment and transmembrane transport of cytotoxic reagents are considered to be effective strategies to increase the efficiency and selectivity of antitumor drugs targeting solid tumors. In the present study, a recombinant protein ABD‑LDP‑Ec consisting of the albumin‑binding domain (ABD), the apoprotein (LDP) of lidamycin (LDM) and an EGFR‑targeting oligopeptide (Ec) was prepared by DNA recombination...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
